Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
on TNF (Tumor Necrosis Factor) and TL1A (TNF-like ligand 1A). Several anti-TL1A antibodies have shown remarkable efficacy in Inflammatory Bowel Disease (IBD) clinical trials but mechanistic details of TL1A
-
AstraZeneca. It aims to transform antibody manufacturing using AI, automation, digital twins and advanced analytics to improve production of therapies for cancer, obesity and autoimmune conditions. Delivered
-
AstraZeneca. It aims to transform antibody manufacturing using AI, automation, digital twins and advanced analytics to improve production of therapies for cancer, obesity and autoimmune conditions. Delivered
-
AstraZeneca. It aims to transform antibody manufacturing using AI, automation, digital twins and advanced analytics to improve production of therapies for cancer, obesity and autoimmune conditions. Delivered
-
, gender identity or expression (whether actual or perceived), sexual orientation, age, height, weight, disability, citizenship status, veteran status, HIV antibody status, political belief, membership in
-
, citizenship status, veteran status, HIV antibody status, political belief, membership in any social or political organization, participation in a grievance or complaint whether formal or informal, medical
-
or pregnancy status, sex, gender identity or expression (whether actual or perceived), sexual orientation, age, height, weight, disability, citizenship status, veteran status, HIV antibody status, political
-
, veteran status, HIV antibody status, political belief, membership in any social or political organization, participation in a grievance or complaint whether formal or informal, medical conditions including
-
contributions. The successful candidate will lead research on the structural and functional characterization of protein antigens and antibody complexes to support vaccine and therapeutic development. Deep
-
are enhancing our oncology research capabilities by establishing dedicated Target Discovery teams within each of our oncology research units: Immuno-Oncology, Antibody Drug Conjugates (ADC), and Cancer Genomics